The FDA cleared The Bigfoot Unity AI Diabetes Management System by Bigfoot Biomedical for T1D & T2D management in patients of 12 or older.  

What motivates type 2 diabetes patients' preferences for either once-daily oral or once-weekly injectable medication? 

Patients experiencing pain along with their diabetic polyneuropathy are at an increased risk of vascular events and mortality.

Older adults with prediabetes or diabetes experienced faster physical functional decline and disability progression.

Both prenatal and first year of life antibiotic exposure may increase the risk for developing type 1 diabetes in childhood.

Continuous glucose monitoring in ICU patients can provide unique benefits to both patients and frontline healthcare workers.

The use of insulin to treat type 2 diabetes patients is growing, but does its risk for hypoglycemia impact cardiovascular health?

A retrospective cohort analyzed the association of two commonly prescribed medications on heart failure outcomes in patients with reduced estimated glomerular filtration rate.

Is QT prolongation the key to understanding the effect of intensive glucose control on diabetes mortality?

A systematic review and meta-analysis of randomized controlled trials examines how some inflammatory markers may be affected by physical activity.